PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt. a.gomma@aun.edu.eg.\', \'Department of Internal Medicine, Faculty of Medicine, Sohag University, Sohag, Egypt.\', \'Department of Medical Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt.\', \'Department of Plastic Surgery, Faculty of Medicine, Assiut University, Assiut, Egypt.\', \'Department of Pharmacology & Toxicology, Faculty of Pharmacy, Assiut University, Assiut, Egypt.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s10787-022-00939-7
?:doi
?:hasPublicationType
?:journal
  • Inflammopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 35233748
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.925
?:rankingScore_hIndex
  • 41
?:title
  • Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35233748>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35233748>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all